Nurix Share Price

Nurix Share Price

NASDAQ: NRIX | Small Cap | Healthcare
$12.85
-$0.74 (-5.45%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Nurix Stock Performance

Open
$13.36
Prev. Close
$13.59
Circuit Range
N/A
Day Range
$12.84 - $13.62
Year Range
$12.84 - $28.18
Volume
1,34,711
Average Traded
$13.02

Nurix Share Price Today

As of 22 November 2026, Nurix Therapeutics, Inc.'s share price is $12.85. The stock opened at $13.36, compared to its previous close of $13.59. During today's trading session, Nurix Therapeutics, Inc.'s share price traded between $12.84 and $13.62, with an average price of $13.23. Over the past 52 weeks, the stock has recorded a high of $28.18 and a low of $12.84. In terms of performance, Nurix Therapeutics, Inc.'s share price has declined by 27.61% over the last six months and is down 27.39% on a year-on-year basis.

Nurix Share Price Chart

Line chart of the Nurix price trend over the selected period. The price fell overall, ranging from 12.84 to 13.65, ending at 12.84.
$12.84$13.62
L
Show Current Price
H

Nurix Stock Fundamentals & Key Indicators

Market Cap
$1.11B
PE Ratio (TTM)
4.76
Dividend Yield
0.00%
EPS (TTM)
$2.70
Revenue (TTM)
$83.98B
Return On Equity (TTM)
30.45%
Profit Margin
-314.91%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
802.90%

Nurix Quarterly Profit & Loss

All figures in USD

ParticularsNov 2025Feb 2026May 2026Aug 2026
Revenue$13.58$6.25$9.04$673.06
Net Profit-$78.22-$87.17-$89.54$549.81
Net Profit Margin-575.99%-1394.72%-990.49%81.69%
Income ChangeN/A-11.44%-2.72%714.04%

Nurix Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$38.63$76.99$54.55$83.98
Net Profit-$180.36-$143.95-$193.57-$264.46
Net Profit Margin-466.89%-186.97%-354.85%-314.91%
Income ChangeN/A20.19%-34.47%-36.62%

Nurix Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets81.3249.9660.198.31
Current Assets606.82619.39295.5318.45
Total Assets688.14669.34355.6416.76
Non Current Liabilities62.9246.568.1542.41
Current Liabilities86.4795.8586.9670.66
Total Liabilities149.39142.35155.11113.06
Shareholders' Equity538.75526.99200.49303.7

Nurix Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-249.47-172.58-81.37-159.81
Investing147.85-257.7168.327.2
Financing238.64485.673.22117.19

About Nurix

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Nurix Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$26.75
$12.87
-51.97%
Oct 2026
$23.60
$26.79
+13.02%
Sep 2026
$25.86
$23.70
-11.78%
Aug 2026
$23.00
$26.86
+15.85%
Jul 2026
$24.52
$23.19
-4.33%
Jun 2026
$17.43
$24.24
+36.60%
May 2026
$16.59
$17.75
+6.26%
Apr 2026
$16.05
$16.70
+7.81%
Mar 2026
$15.45
$15.49
-3.10%
Feb 2026
$16.28
$15.98
-3.27%
Jan 2026
$18.89
$16.52
-13.21%
Dec 2025
$17.22
$19.04
+7.63%

Nurix Share Price FAQs